Preferred Label : triiodothyronine;
MeSH definition : A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much
smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination
of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone
finally delivered and used by the tissues is mainly T3.;
MeSH synonym : thyroid hormone, t3; t3 thyroid hormone;
CISMeF synonym : liothyronine;
CISMeF acronym : T3;
MeSH hyponym : cytomel; 3,3',5-Triiodothyronine;
MeSH CAS label : L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-;
MeSH Related Number : 6893-02-3 (Triiodothyronine); GCA9VV7D2N;
Registry Number MeSH : 6893-02-3;
Wikipedia link : https://en.wikipedia.org/wiki/Triiodothyronine;
Codes EINECS : 229-999-3;
Is substance : O;
UNII : 06LU7C9H1V;
InChIKey : AUYYCJSJGJYCDS-LBPRGKRZSA-N;
Origin ID : D014284;
UMLS CUI : C0041014;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Indexing information
Manual BTNT mappings - CISMeF
Record concept(s)
Related MeSH Supplementary Concept(s)
- redotex [MeSH Supplementary Concept]
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much
smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination
of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone
finally delivered and used by the tissues is mainly T3.
https://www.ema.europa.eu/en/medicines/human/EPAR/emcitate
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
3,3',5-triiodothyroacetic acid
3,3',5-triiodothyroacetic acid
orphan drug production
tiratricol
drug approval
europe
triiodothyronine
thyrotoxicosis
Allan-Herndon-Dudley Syndrome
administration, oral
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
---
https://www.has-sante.fr/jcms/p_3190711/fr/cynomel
2020
false
false
false
France
administration, oral
triiodothyronine
liothyronine sodium
treatment outcome
insurance, health, reimbursement
hypothyroidism
thyroid hormone resistance syndrome
pregnancy
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1773266/fr/cynomel
http://www.has-sante.fr/portail/jcms/c_724419/cynomel
2014
false
France
French
Liothyronine Sodium
thyroid hormone resistance syndrome
hormone replacement therapy
triiodothyronine
administration, oral
liothyronine sodium
insurance, health, reimbursement
hypothyroidism
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1773257/fr/euthyral
http://www.has-sante.fr/portail/jcms/c_1172443/euthyral
http://www.has-sante.fr/portail/jcms/c_751104/euthyral
2014
false
France
French
levothyroxine sodium
thyroxine, triiodothyronine drug combination
thyroxine
drug combinations
administration, oral
triiodothyronine
insurance, health, reimbursement
combinations of levothyroxine and liothyronine
hypothyroidism
adult
child
treatment outcome
meta-analysis as topic
evaluation of the transparency committee
---
http://www.meddispar.fr/Medicaments/TEATROIS-0.35-B-100/(type)/letter/(value)/T/(cip)/3400931737353
2014
false
true
false
France
French
drug information
3,3',5-triiodothyroacetic acid
tiratricol
administration, oral
legislation, drug
drug prescriptions
triiodothyronine
triiodothyronine
---